Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Pyrimidines >  Methoxy-pyrimidine >  4-Pyrimidinamine, 5-methoxy- (9CI)

4-Pyrimidinamine, 5-methoxy- (9CI)

Basic information Safety Supplier Related

4-Pyrimidinamine, 5-methoxy- (9CI) Basic information

Product Name:
4-Pyrimidinamine, 5-methoxy- (9CI)
Synonyms:
  • 4-Pyrimidinamine, 5-methoxy- (9CI)
  • 4-Amino-5-methoxypyrimidine
  • 5-MethoxypyriMidin-4-aMine
  • 4-amino-5-methoxypyrimdine
  • 5-Methoxy-4-pyrimidinamine
  • 4-Pyrimidinamine, 5-methoxy-
  • 4-Pyrimidinamine, 5-methoxy- (9CI) ISO 9001:2015 REACH
CAS:
695-86-3
MF:
C5H7N3O
MW:
125.13
Product Categories:
  • PYRIMIDINE
Mol File:
695-86-3.mol
More
Less

4-Pyrimidinamine, 5-methoxy- (9CI) Chemical Properties

Melting point:
118.5-119.0 °C
Boiling point:
264.3±20.0 °C(Predicted)
Density 
1.224±0.06 g/cm3(Predicted)
storage temp. 
under inert gas (nitrogen or Argon) at 2–8 °C
pka
5.04±0.10(Predicted)
Appearance
Off-white to light yellow Solid
More
Less

4-Pyrimidinamine, 5-methoxy- (9CI) Usage And Synthesis

Synthesis

695-85-2

695-86-3

General procedure for the synthesis of 4-amino-5-methoxypyrimidines from 4-chloro-5-methoxypyrimidines: 4-chloro-5-methoxypyrimidines (I-89) (40 g, 280 mmol) was suspended in NH3(g)/EtOH (4 M, 2000 mL), the suspension was transferred to an autoclave, and the reaction was stirred for 12 hours at 130 °C. The progress of the reaction was monitored by TLC (unfolding agent: CH2Cl2/MeOH = 10:1) and after confirming the completion of the reaction, the reaction mixture was cooled to room temperature. Subsequently, the mixture was concentrated under vacuum to obtain the residue. CH2Cl2 (100 mL) was added to the residue and stirred at room temperature for 30 minutes. The reaction mixture was filtered to remove the NH4Cl salt and the filtrate was concentrated under vacuum to give the crude product. The crude product was stirred with a solvent mixture of EtOAc/CH2Cl2 (50 mL, 4:1) for 30 min, filtered and concentrated in vacuum to give the final 4-amino-5-methoxypyrimidine (I-90) (30 g, 87% yield) as a yellow solid. The structure of the product was confirmed by 1H NMR (400 MHz, DMSO-d6): δ 8.01 (s, 1H), 7.81 (s, 1H), 6.75 (br.s., 2H), 3.81 (s, 3H).

References

[1] Patent: WO2016/97918, 2016, A1. Location in patent: Page/Page column 80
[2] Organic Process Research and Development, 2015, vol. 19, # 6, p. 639 - 645
[3] European Journal of Medicinal Chemistry, 2009, vol. 44, # 10, p. 4179 - 4191

4-Pyrimidinamine, 5-methoxy- (9CI)Supplier

PharmaBlock Sciences (Nanjing),Inc.
Tel
025-86918202 4000255188
Email
sales@pharmablock.com
BeiJing Hwrk Chemicals Limted
Tel
0757-86329057 18934348241
Email
sales4.gd@hwrkchemical.com
Shanghai Hanhong Scientific Co.,Ltd.
Tel
021-54306202 13764082696
Email
info@hanhongsci.com
Shandong Xiya Chemical Co., Ltd
Tel
4009903999 13355009207
Email
3007715519@qq.com
Shanghai Sunway Pharmaceutical Technology Co., Ltd
Tel
18270980682
Email
mlcheng@sunwaypharm.cn